mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
0.0006 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0008 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |